167764-63-8Relevant articles and documents
COMPOUNDS FORTREATMENT OF CARDIOVASCULAR DISEASES
-
, (2008/06/13)
Pharmaceutical compositions containing sodium-hydrogen exchanger type 1 (NHE-1) inhibitors in combination with Ca 2+ overload inhibitors, and the use of such combination inhibitors to treat, for example, cardiovascular disease, such as ischemia, particularly, perioperative myocardial ischemic injury in mammals, including humans, are disclosed.